Pilot & Feasibility
Protocols & Methods
Reagents & Resources
Tissues & Samples
IMPC / KOMP Data
Pilot & Feasibility
Drug Discovery to Halt the Progression of Acute Kidney Injury to Chronic Kidney
Disease: A Case for Phenotypic Drug Discovery in Acute Kidney Injury.
Hukriede N, Vogt A, de Caestecker M
Mark P. de Caestecker on 7/3/2017
Volume : Pages
The cellular responses that occur following acute kidney injury (AKI) are
complex and dynamic, involving multiple cells types and molecular pathways. For
this reason, early selection of defined molecular targets for therapeutic
intervention is unlikely to be effective in complex in vivo models of AKI, let
alone Phase 3 clinical trials in patients with even more complex AKI
pathobiology. Phenotypic screening using zebrafish provides an attractive
alternative that does not require prior knowledge of molecular targets and may
identify compounds that modify multiple targets that might be missed in more
traditional target-based screens. In this review, we discuss results of an
academic drug discovery campaign that used zebrafish as a primary screening tool
to discover compounds with favorable absorption, metabolism, and toxicity that
enhance repair when given late after injury in multiple models of AKI. We
discuss how this screening campaign is being integrated into a more
comprehensive, phenotypic, and target-based screen for lead compound
Investigators with authorship
Mark P. de Caestecker
Neuropathy & Neurocognition
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an external advisor to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!